Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolo Girometti

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
The Lancet. HIV|May 29, 2020
HIV postexposure prophylaxis during COVID-19Muhammad Junejo, Nicolo Girometti, Alan McOwan, et al.
HIV Medicine|June 7, 2026
Prior PrEP use and discontinuation in individuals newly diagnosed with HIVRohan Saini, Sarah Fidler, Marta Boffito, et al.
Journal of the International AIDS Society|December 5, 2022
Intersecting HIV and mpox epidemics: more questions than answersNicolo Girometti, Dimie Ogoina, Darrell H S Tan, et al.
The Lancet. HIV|March 19, 2022
Delivering specialised care to people ageing with HIV in the UK: experience and evolution of services from 2009 to 2019Ana Milinkovic, Branca Pereira, Maria Mazziteli, et al.
Sexually Transmitted Infections|February 16, 2022
Complex PrEP: the factors requiring consultant-led review of PrEP usersVictoria Tittle, Rebecca Dalton, Diarmuid Nugent, et al.
International Journal of STD & AIDS|April 5, 2022
Correlation between different equations to calculate free testosterone for improved detection of hypogonadism in people living with HIVShuang Wu, Orla Hilton, Branca Pereira, et al.
Sexually Transmitted Infections|February 13, 2025
Real-world experience of renal outcomes and management of PrEP users with estimated glomerular filtration rates less than 60 mL/min/1.73 m<sup>2</sup>Victoria Tittle, Nicolo Girometti, Jonathan Joseph Goodfellow, et al.
Sexually Transmitted Infections|August 1, 2024
<i>Mycoplasma genitalium</i> treatment outcomes among a cohort failing macrolide resistance-guided treatment across three London sexual health clinicsKate Johnson, Ella Buluwela, Gemma McDonald, et al.
Sexual Health|September 26, 2018
Evolution of a pre-exposure prophylaxis (PrEP) service in a community-located sexual health clinic: concise report of the PrEPxpressNicolo Girometti, Sheena McCormack, Emma Devitt, et al.
International Journal of STD & AIDS|November 24, 2023
Direct switch from an efavirenz-based regimen to intramuscular long-acting cabotegravir plus rilpivirine: A case reportElizabeth Senkoro, Margherita Bracchi, Joseph Heskin, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
The Lancet. HIV|May 29, 2020
HIV postexposure prophylaxis during COVID-19Muhammad Junejo, Nicolo Girometti, Alan McOwan, et al.
HIV Medicine|June 7, 2026
Prior PrEP use and discontinuation in individuals newly diagnosed with HIVRohan Saini, Sarah Fidler, Marta Boffito, et al.
Journal of the International AIDS Society|December 5, 2022
Intersecting HIV and mpox epidemics: more questions than answersNicolo Girometti, Dimie Ogoina, Darrell H S Tan, et al.
The Lancet. HIV|March 19, 2022
Delivering specialised care to people ageing with HIV in the UK: experience and evolution of services from 2009 to 2019Ana Milinkovic, Branca Pereira, Maria Mazziteli, et al.
Sexually Transmitted Infections|February 16, 2022
Complex PrEP: the factors requiring consultant-led review of PrEP usersVictoria Tittle, Rebecca Dalton, Diarmuid Nugent, et al.
International Journal of STD & AIDS|April 5, 2022
Correlation between different equations to calculate free testosterone for improved detection of hypogonadism in people living with HIVShuang Wu, Orla Hilton, Branca Pereira, et al.
Sexually Transmitted Infections|February 13, 2025
Real-world experience of renal outcomes and management of PrEP users with estimated glomerular filtration rates less than 60 mL/min/1.73 m<sup>2</sup>Victoria Tittle, Nicolo Girometti, Jonathan Joseph Goodfellow, et al.
Sexually Transmitted Infections|August 1, 2024
<i>Mycoplasma genitalium</i> treatment outcomes among a cohort failing macrolide resistance-guided treatment across three London sexual health clinicsKate Johnson, Ella Buluwela, Gemma McDonald, et al.
Sexual Health|September 26, 2018
Evolution of a pre-exposure prophylaxis (PrEP) service in a community-located sexual health clinic: concise report of the PrEPxpressNicolo Girometti, Sheena McCormack, Emma Devitt, et al.
International Journal of STD & AIDS|November 24, 2023
Direct switch from an efavirenz-based regimen to intramuscular long-acting cabotegravir plus rilpivirine: A case reportElizabeth Senkoro, Margherita Bracchi, Joseph Heskin, et al.
Pageof 3